Table 4 Loss of function variants identified in the five gene candidates.
Phenotype | Gene | Transcript | Protein change | Info | gnomAD AF | G&H AF^ | ACMG-AMP | ACMG-AMP criteria | Clinvar |
|---|---|---|---|---|---|---|---|---|---|
ICP | ABCB4 | ENSP00000395716.1:p.Ser99LeufsTer11 | S99x | Frameshift | 0.00039970 | 0.00336538 | P | PVS1, PM2, PP3 | |
ENSP00000392983.1:p.Leu759TyrfsTer38 | F758x | Frameshift | 0.00009610 | LP | PVS1, PM2 | ||||
ENSP00000392983.1:p.Lys30GlyfsTer7 | Lys30Glyfster7 | Frameshift | 0.00000408 | 0.00020243 | LP | PVS1, PM2 | |||
ENSP00000392983.1:p.Arg595Ter | R595* | Stop-gained | 0.00001627 | 0.00009593 | P | PVS1, PM2, PP3, PP5 | Pathogenic | ||
Gallstone disease | ABCB11 | ENSP00000497931.1:p.Ala1044LeufsTer53 | A1044x | Frameshift | 0.00009562 | P | PVS1, PM2, PP3 | ||
ENST00000263817.7:c.2611-2A > T | c.2611-2A > T | Splice-acceptor-variant | 0.00000407 | 0.00057870 | P | PVS1, PM2, PP3 | |||
ENSP00000497931.1:p.Trp239Ter | W239x | Stop-gained | 0.00009566 | P | PVS1, PM2, PP3 | ||||
ATP8B1 | ENSP00000283684.4:p.Gln1179GlufsTer56 | IQ1178-1179IX | Frameshift_variant & splice_region_variant | 0.00193798 | |||||
ENSP00000283684.4:p.Pro792HisfsTer8 | F791X | frameshift_variant | 0.00019069 | P | PVS1, PM2, PP3 | ||||
Gallstone disease | ENST00000283684.9:c.182-4_183del | ?-61 | Splice_acceptor_variant & coding_sequence_variant & intron_variant | 0.00048956 | |||||
ENSP00000283684.4:p.Glu20Ter | E20* | Stop_gained | 0.00009566 | P | PVS1, PM2, PP3 | ||||
NR1H4 | ENSP00000446760.1:p.Lys4Ter | K4* | Stop_gained | 0.00014188 | P | PVS1, PM2, PP3 | |||
TJP2 | ENSP00000438262.1:p.Glu44Ter | E44* | Stop_gained | 0.00009604 | LP | PVS1, PM2 | |||
ENSP00000345893.4:p.Gly5ArgfsTer26 | M1MPVX | Frameshift_variant & start_lost | 0.00001343 | 0.00029768 | P | PVS1, PM2, PP3 |